Versatrol Controlled Release SoftgelsSource: Patheon Inc.
Innovative controlled release delivery system employs unique matrix formulations for both lipophilic and hydrophilic compounds. Compatible with proprietary EnteriCare® enteric softgels technology enabling delivery of the active ingredient directly to the small intestine.
Key Dosage Form Characteristics
- Controlled release softgel for both lipophilic and hydrophilic compounds
- Customized and more predictable release profile achieved by tailoring the formulation variables
- Unique matrix formulations
- Ability to customize release profiles
- Compatible with proprietary EnteriCare® enteric softgels technology
- Patent pending technology